The 2022 BRACE Award Venture Competition is open for applications until 28 February 2022, 11:59 PM Hong Kong Time.

Apply Now

The Asian Fund for Cancer Research (AFCR) is proud to present the BRACE Award, Bridging Research from Academia to Cancer Entrepreneurship. The program is designed to advance and catalyze the commercialization of innovative cancer research discoveries. AFCR is committed to bridging the gap in funding for promising start-ups through the “Valley of Death”, especially those spun-out of top universities and medical centers in Asia. The initiative provides a combination of investment capital, exposure-generating opportunities and enhanced access to AFCR’s network of cancer industry professionals and researchers in the region and around the world.

The winning company will receive US$600,000 in investment funding from AFCR and co-investors, subject to due diligence and negotiation, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

2021 BRACE - Chimera

2021 BRACE Award Venture Competition

The Asian Fund for Cancer Research is pleased to announce Chimera Bioengineering as the WINNER of the 2021 BRACE Award Venture Competition. The start-up company is developing an innovative CAR-T cell therapeutic technology platform targeting solid tumors. Congratulations to Chimera and the AFCR event’s Second Place Winner, Believer Inc., as well as Best Public Communicator, KYAN Therapeutics.

Supporters & Sponsors

Ready to do more?

Help double the impact for early-stage oncology start-ups that are creating life-saving innovations!

Sign up for e-mails to learn about future BRACE Award Competitions and other developments.